Cardiac fibroblast inflammasome and atrial myopathy

心脏成纤维细胞炎症小体与心房肌病

基本信息

  • 批准号:
    10597243
  • 负责人:
  • 金额:
    $ 69.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-03-25 至 2026-02-28
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Atrial fibrillation (AF) is the most frequent arrhythmia. Atrial myopathy is a key determinant of the development of AF. The molecular mechanisms underlying the evolution of AF-promoting atrial myopathy are complex and poorly understood. Innate inflammatory signaling including the ‘NLR family pyrin domain containing 3’ (NLRP3) inflammasome pathway can modulate cardiac function and atrial arrhythmogenesis. Our preliminary study revealed that NLRP3 inflammasome activity is enhanced in atrial cardiac fibroblasts (CFs) of persistent AF patients compared with sinus rhythm controls. The CF-specific activation of NLRP3 in mice promotes the development of atrial fibrosis, enlarged left atrium, reduced atrial contractility, abnormal impulse conduction, sinus node dysfunction, and increased AF susceptibility, phenocopying atrial myopathy associated with AF development. In this proposal, we will test the hypothesis that activation of CF inflammasomes enhances atrial arrhythmogenesis by promoting atrial myopathy. Additionally, the therapeutic potential of enhancing the resolution of inflammation to combat atrial myopathy and atrial arrhythmogenesis deserves evaluation. In this proposal, we will also evaluate whether an inducer of inflammation resolution can prevent the inflammasome- induced atrial myopathy, thereby reducing atrial arrhythmogenesis. This proposal addresses several understudied areas in AF pathogenesis. The outcome of this study will provide novel insights into the development of atrial myopathy and sinus node dysfunction, as well as provide rationale for using the pro- resolution molecule in AF prevention.
项目摘要 心房颤动(AF)是最常见的心律失常。心房肌病是发展的关键决定因素 AF促进性心房肌病变演变的分子机制是复杂的, 不太了解。天然炎症信号传导,包括“含NLR家族pyrin结构域3”(NLRP3) 炎性小体通路可调节心功能和心房颤动的发生。我们的初步研究 显示NLRP 3炎性小体活性在持续性AF的心房心脏成纤维细胞(CF)中增强 与窦性心律对照组比较。小鼠中NLRP 3的CF特异性激活促进了细胞内的细胞凋亡。 心房纤维化的发展,左心房增大,心房收缩力降低,异常冲动传导, 窦房结功能障碍,房颤易感性增加,与房颤相关的房性肌病表型 发展在这个建议中,我们将测试CF炎性小体激活增强心房肌细胞增殖的假设。 通过促进心房肌病变而引起心房肌病变。此外,增强免疫抑制剂的治疗潜力也是一个潜在的问题。 对抗心房肌病和心房肌纤维化的炎症消退值得评价。在这 建议,我们还将评估炎症消退诱导剂是否可以预防炎性小体, 诱发心房肌病变,从而减少心房肌的发生。该提案涉及几个 AF发病机制研究不足的领域。这项研究的结果将提供新的见解, 心房肌病变和窦房结功能障碍的发展,以及提供使用前 分辨率分子在预防房颤中的作用

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Na Li其他文献

Na Li的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Na Li', 18)}}的其他基金

The Role of Gasdermin-D/Interleukin-1 Nexus in Atrial Arrhythmogenesis
Gasdermin-D/IL-1 Nexus 在房性心律失常发生中的作用
  • 批准号:
    10531927
  • 财政年份:
    2021
  • 资助金额:
    $ 69.97万
  • 项目类别:
The Role of Gasdermin-D/Interleukin-1 Nexus in Atrial Arrhythmogenesis
Gasdermin-D/IL-1 Nexus 在房性心律失常发生中的作用
  • 批准号:
    10363449
  • 财政年份:
    2021
  • 资助金额:
    $ 69.97万
  • 项目类别:
The Role of Gasdermin-D/Interleukin-1 Nexus in Atrial Arrhythmogenesis
Gasdermin-D/IL-1 Nexus 在房性心律失常发生中的作用
  • 批准号:
    10779536
  • 财政年份:
    2021
  • 资助金额:
    $ 69.97万
  • 项目类别:
Mechanisms underlying atrial fibrillation associated with chronic kidney disease
与慢性肾脏病相关的心房颤动的机制
  • 批准号:
    10376782
  • 财政年份:
    2019
  • 资助金额:
    $ 69.97万
  • 项目类别:
Mechanisms underlying atrial fibrillation associated with chronic kidney disease
与慢性肾脏病相关的心房颤动的机制
  • 批准号:
    9913385
  • 财政年份:
    2019
  • 资助金额:
    $ 69.97万
  • 项目类别:
Inflammasome mediated pathogenesis of atrial fibrillation
炎症小体介导的房颤发病机制
  • 批准号:
    9336416
  • 财政年份:
    2016
  • 资助金额:
    $ 69.97万
  • 项目类别:
New Building Blocks for the Synthesis of Modified RNAs
用于合成修饰 RNA 的新构件
  • 批准号:
    8252504
  • 财政年份:
    2012
  • 资助金额:
    $ 69.97万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 69.97万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.97万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 69.97万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.97万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 69.97万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 69.97万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.97万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 69.97万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 69.97万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.97万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了